Skip to content
10-Q/A

Quarterly Report

CALLISTO PHARMACEUTICALS INC

0001104659-12-060480

← back to feed
Filed
Aug 28, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 17, 2012 158.97M sh
Shares Diluted Q2 2012 · Jun 30, 2012 158.63M sh
Shares Diluted Q2 2012 · Jun 30, 2012 158.63M sh
Shares Diluted Q2 2012 · Jun 30, 2011 158.51M sh
Shares Diluted Q2 2012 · Jun 30, 2011 158.08M sh
Capex Q2 2012 · Jun 30, 2012 $117.23K
Cash And Equivalents Q2 2012 · Jun 30, 2012 $120
Cash And Equivalents Q2 2012 · Dec 31, 2011 $13.24M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $598.1K
Cash And Equivalents Q2 2012 · Dec 31, 2010 $1.71M
Stockholders Equity Q2 2012 · Jun 30, 2012 $113.91M
Stockholders Equity Q2 2012 · Dec 31, 2011 $26.18M
Current Liabilities Q2 2012 · Jun 30, 2012 $2.04M
Current Liabilities Q2 2012 · Dec 31, 2011 $4.66M
Total Liabilities Q2 2012 · Jun 30, 2012 $3.98M
Total Liabilities Q2 2012 · Dec 31, 2011 $7.99M
Current Assets Q2 2012 · Jun 30, 2012 $120
Current Assets Q2 2012 · Dec 31, 2011 $14.42M
Total Assets Q2 2012 · Jun 30, 2012 $117.89M
Total Assets Q2 2012 · Dec 31, 2011 $14.51M
Eps Diluted Q2 2012 · Jun 30, 2012 $0.74
Eps Diluted Q2 2012 · Jun 30, 2012 $0.72
Eps Diluted Q2 2012 · Jun 30, 2011 −$0.02
Eps Diluted Q2 2012 · Jun 30, 2011 −$0.03
Eps Basic Q2 2012 · Jun 30, 2012 $0.74
Eps Basic Q2 2012 · Jun 30, 2012 $0.72
Eps Basic Q2 2012 · Jun 30, 2011 −$0.02
Eps Basic Q2 2012 · Jun 30, 2011 −$0.03
Sga Expense Q2 2012 · Jun 30, 2012 $805.19K
Sga Expense Q2 2012 · Jun 30, 2012 $2.76M
Sga Expense Q2 2012 · Jun 30, 2012 $63.13M
Sga Expense Q2 2012 · Jun 30, 2011 $1.88M
Sga Expense Q2 2012 · Jun 30, 2011 $3.84M
Net Income Q2 2012 · Jun 30, 2012 $116.91M
Net Income Q2 2012 · Jun 30, 2012 $113.77M
Net Income Q2 2012 · Jun 30, 2012 −$9.49M
Net Income Q2 2012 · Jun 30, 2011 −$2.5M
Net Income Q2 2012 · Jun 30, 2011 −$4.26M
Operating Income Q2 2012 · Jun 30, 2012 −$3.35M
Operating Income Q2 2012 · Jun 30, 2012 −$10.64M
Operating Income Q2 2012 · Jun 30, 2012 −$135.92M
Operating Income Q2 2012 · Jun 30, 2011 −$4.23M
Operating Income Q2 2012 · Jun 30, 2011 −$7.56M